OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antamanide Analogs as Potential Inhibitors of Tyrosinase
Claudia Honisch, Matteo Gazziero, Roberto Dallocchio, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6240-6240
Open Access | Times Cited: 9

Showing 9 citing articles:

Synthesis, anti-browning effect and mechanism research of kojic acid-coumarin derivatives as anti-tyrosinase inhibitors
Min He, Jinfeng Zhang, Na Li, et al.
Food Chemistry X (2024) Vol. 21, pp. 101128-101128
Open Access | Times Cited: 10

Friedel–Crafts reactions for biomolecular chemistry
Jun Ohata
Organic & Biomolecular Chemistry (2024) Vol. 22, Iss. 18, pp. 3544-3558
Open Access | Times Cited: 5

Peptide Design for Enhanced Anti-Melanogenesis: Optimizing Molecular Weight, Polarity, and Cyclization
Sheila Amara Putri, Rani Maharani, Iman Permana Maksum, et al.
Drug Design Development and Therapy (2025) Vol. Volume 19, pp. 645-670
Open Access

Bioactive Peptides in Human Health and Disease
Serena Martini, Davide Tagliazucchi
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5837-5837
Open Access | Times Cited: 12

Targeting the vital non-structural proteins (NSP12, NSP7, NSP8 and NSP3) from SARS-CoV-2 and inhibition of RNA polymerase by natural bioactive compound naringenin as a promising drug candidate against COVID-19
Elahe Aleebrahim‐Dehkordi, Hamed Ghoshouni, Pooneh Koochaki, et al.
Journal of Molecular Structure (2023) Vol. 1287, pp. 135642-135642
Open Access | Times Cited: 8

A new strategy for the treatment of Parkinson’s disease: Discovery and bio-evaluation of the first central-targeting tyrosinase inhibitor
Shulei Qi, Lina Guo, Jinxin Liang, et al.
Bioorganic Chemistry (2024) Vol. 150, pp. 107612-107612
Closed Access | Times Cited: 2

Inhibitory Effect of Curcumin-Inspired Derivatives on Tyrosinase Activity and Melanogenesis
Gaia Rocchitta, Carla Rozzo, Marina Pisano, et al.
Molecules (2022) Vol. 27, Iss. 22, pp. 7942-7942
Open Access | Times Cited: 5

Page 1

Scroll to top